BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

Study Details The Sheddase To Target For Anti-Allergy Success

Nov. 13, 2006
By Anette Breindl

Study Details The Sheddase To Target For Anti-Allergy Success

Nov. 13, 2006
By Anette Breindl

Studying Cell Division, Without Cells, Yields Novel BRCA1 Role

Nov. 8, 2006
By Anette Breindl

Studying Cell Division, Without Cells, Yields Novel BRCA1 Role

Nov. 8, 2006
By Anette Breindl

Anti-Aging Compound In Clinic For Possible Effect On Diabetes

Nov. 2, 2006
By Anette Breindl

Anti-Aging Compound In Clinic For Possible Effect On Diabetes

Nov. 2, 2006
By Anette Breindl

How Cells Deliver Message To Proper Address, Avoid Pileups

Oct. 31, 2006
By Anette Breindl

How Cells Deliver Message To Proper Address, Avoid Pileups

Oct. 31, 2006
By Anette Breindl

Gene Variant Offers Protection In Inflammatory Bowel Disease

Oct. 30, 2006
By Anette Breindl

Gene Variant Offers Protection In Inflammatory Bowel Disease

Oct. 30, 2006
By Anette Breindl
Previous 1 2 … 352 353 354 355 356 357 358 359 360 … 401 402 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing